Inflammatory bowel disease treatment in the time of COVID: Patient perceptions and decision-making (Cindy Kin, Sarah Streett)

Kin and Streett are exploring how people with inflammatory bowel diseases, including people with Crohn’s disease and ulcerative colitis whose treatment frequently involves chronic immunosuppressive therapies, are affected by the COVID-19 outbreak. The study aims to understand the primary concerns that patients with inflammatory bowel diseases have about their illnesses and treatments as they relate to the COVID-19 epidemic so that physicians and the health care team can effectively engage them in shared decision-making. Stanford Office of Technology Licensing 650-723-0651

Related Blog

Smart, interactive desk

Get ready to take your space management game to the next level with the University of Glasgow’s innovative project! By combining the

Mechanical Hamstring™

University of Delaware Technology Overview This device was created to allow athletes who suffer a hamstring strain to return to the field

Join Our Newsletter

                                                   Receive Innovation Updates, New Listing Highlights And More